RSS
5 Jan 2021

Sosei Heptares to Regain Worldwide Rights to Muscarinic Agonist Programs

Author: admintech | Filed under: Press Release

TOKYO and CAMBRIDGE, England, Jan. 5, 2021 /PRNewswire/ — Sosei Group Corporation (“the Company”) (TSE: 4565) announces it is to regain the worldwide rights to its muscarinic agonist programs. The program was licensed to Allergan in April 2016, and Allergan was acquired by AbbVie in May…

This entry was posted on Tuesday, January 5th, 2021 at 2:26 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»